Concepedia

Shogo Kobayashi

SK

Statistics

Publications

202

Citations

9.8K

H-Index

56

Active since

1977

Affiliations

The University of Osaka(Current)

Osaka International Cancer Institute

Kansai Rosai Hospital

Osaka City University

Osaka Police Hospital

Shogo Kobayashi is an author at The University of Osaka specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1977–2024

202

Publications

202

mir-29 regulates Mcl-1 protein expression and apoptosis

Justin L. Mott, Shogo Kobayashi, Steven F. Bronk et al. · Oncogene · 2007 · 829 citations · Full text

, , +12

Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

Yoshito Tomimaru, Hidetoshi Eguchi, Hiroaki Nagano et al. · Journal of Hepatology · 2011 · 360 citations

, , +14

Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)

Tatsuya Ioka, Masashi Kanai, Shogo Kobayashi et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2022 · 237 citations · Full text

, , +14

Interleukin 6 upregulates myeloid cell leukemia‐1 expression through a STAT3 pathway in cholangiocarcinoma cells†

Hajime Isomoto, Shogo Kobayashi, Nathan W. Werneburg et al. · Hepatology · 2005 · 225 citations · Full text

, , +17

Interleukin-6 Contributes to Mcl-1 Up-regulation and TRAIL Resistance via an Akt-Signaling Pathway in Cholangiocarcinoma Cells

Shogo Kobayashi, Nathan W. Werneburg, Steven F. Bronk et al. · Gastroenterology · 2005 · 225 citations

, , +17

1–5 of 202